Is PYXS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PYXS. It does not provide personalized investment advice.

PYXS (Pyxis Oncology, Inc. Common Stock) Stock Analysis - Financials

Pyxis Oncology, Inc. Common Stock (PYXS) is a publicly traded Healthcare sector company. As of September 1, 2026, PYXS trades at $3.25 with a market cap of $269.41M and a P/E ratio of -2.23. PYXS moved +0.00% today. Year to date, PYXS is +181.74%; over the trailing twelve months it is +153.13%. Its 52-week range spans $0.83 to $5.55. Analyst consensus is strong buy with an average price target of $7.14. Rallies surfaces PYXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PYXS's key financials?

PYXS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PYXS recently traded at $3.25. Market cap is $269.41M. P/E ratio is -2.23. Revenue is $11.04M.

PYXS Key Metrics

Key financial metrics for PYXS
Metric	Value
Price	$3.25
Market Cap	$269.41M
P/E Ratio	-2.23
EPS	$-1.40
Dividend Yield	0.00%
52-Week High	$5.55
52-Week Low	$0.83
Volume	18.38K
Avg Volume	0
Revenue (TTM)	$11.04M
Net Income	$-88.73M
Gross Margin	0.00%

PYXS Analyst Consensus

8 analysts cover PYXS: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.14.

Common questions about PYXS

What are PYXS's key financials?: PYXS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PYXS recently traded at $3.25. Market cap is $269.41M. P/E ratio is -2.23. Revenue is $11.04M.
Is PYXS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PYXS. It does not provide personalized investment advice.